Healthcare Utilization and Treatment Patterns in Diabetic Macular Edema in Korea: a Retrospective Chart Review
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Kyu Hyung | - |
dc.contributor.author | Kim, Yun Young | - |
dc.contributor.author | Jo, Young Joon | - |
dc.contributor.author | Oh, Jaeryung | - |
dc.contributor.author | Lee, Joo Eun | - |
dc.contributor.author | Lee, Ji Eun | - |
dc.contributor.author | Park, Dong Ho | - |
dc.contributor.author | Kang, Se Woong | - |
dc.contributor.author | Lee, Won Ki | - |
dc.contributor.author | Kim, Ha Kyoung | - |
dc.contributor.author | Adena, Michael | - |
dc.contributor.author | Tan, Jonathan | - |
dc.contributor.author | Kim, Si Dong | - |
dc.date.accessioned | 2021-09-01T16:01:34Z | - |
dc.date.available | 2021-09-01T16:01:34Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-04-22 | - |
dc.identifier.issn | 1011-8934 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/65980 | - |
dc.description.abstract | Background: Limited data exist on real-world treatment patterns for diabetic macular edema (DME) in Korea. In this study, we investigated DME treatment patterns from 2009 to 2014 and the impact of baseline treatment on healthcare resource utilization and visual acuity (VA) outcomes. Methods: A retrospective cohort chart review of DME patients treated at 11 hospital ophthalmology clinics between January 1, 2012 and December 31, 2013 was conducted. We collected data on demographics, healthcare resource utilization (clinic visits, treatment visits, and visits for ocular investigations), distribution of DME treatments, and VA. Results: Overall, 522 DME patients (men, 55.2%; mean age, 59 years; mean HbA1c [n = 209], 8.4%) with 842 DME eyes were evaluated. For all treatments, healthcare resource utilization was significantly higher during the first 6 months versus months 7-12, year 2, or year 3 (P <= 0.001), but was highest for patients whose first treatment was an anti-vascular endothelial growth factor (VEGF) treatment (visits/quarter; anti-VEGF, 1.9; corticosteroids, 1.7; laser, 1.4). Use of macular laser therapy decreased (44% to 8%), whereas use of anti-VEGF injections increased (44% to 69%) during the study period. However, VA improvement was not commensurate with healthcare resource utilization of anti-VEGF treatment (mean VA gain, 2.7 letters). Conclusion: A trend toward increasing use of intravitreal anti-VEGF injections for DME treatment was observed in Korea. However, the frequency of dosing and monitoring was lower in clinical practice versus major clinical trials, which may have led to the less-than-favorable improvements in visual outcomes. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ACAD MEDICAL SCIENCES | - |
dc.subject | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject | RANIBIZUMAB PLUS PROMPT | - |
dc.subject | DEFERRED LASER | - |
dc.subject | INTRAVITREAL DEXAMETHASONE | - |
dc.subject | NATIONAL-HEALTH | - |
dc.subject | RISK-FACTORS | - |
dc.subject | RESOURCE USE | - |
dc.subject | REAL-WORLD | - |
dc.subject | RETINOPATHY | - |
dc.subject | TRIAL | - |
dc.title | Healthcare Utilization and Treatment Patterns in Diabetic Macular Edema in Korea: a Retrospective Chart Review | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Oh, Jaeryung | - |
dc.identifier.doi | 10.3346/jkms.2019.34.e118 | - |
dc.identifier.scopusid | 2-s2.0-85065076867 | - |
dc.identifier.wosid | 000465100600002 | - |
dc.identifier.bibliographicCitation | JOURNAL OF KOREAN MEDICAL SCIENCE, v.34, no.15 | - |
dc.relation.isPartOf | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.title | JOURNAL OF KOREAN MEDICAL SCIENCE | - |
dc.citation.volume | 34 | - |
dc.citation.number | 15 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002457996 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject.keywordPlus | RANIBIZUMAB PLUS PROMPT | - |
dc.subject.keywordPlus | DEFERRED LASER | - |
dc.subject.keywordPlus | INTRAVITREAL DEXAMETHASONE | - |
dc.subject.keywordPlus | NATIONAL-HEALTH | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | RESOURCE USE | - |
dc.subject.keywordPlus | REAL-WORLD | - |
dc.subject.keywordPlus | RETINOPATHY | - |
dc.subject.keywordPlus | TRIAL | - |
dc.subject.keywordAuthor | Anti-VEGF | - |
dc.subject.keywordAuthor | Clinical Practice Patterns | - |
dc.subject.keywordAuthor | Intravitreal Injections | - |
dc.subject.keywordAuthor | Laser Therapy | - |
dc.subject.keywordAuthor | Visual Acuity | - |
dc.subject.keywordAuthor | Visual Outcomes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.